Professor Shai Izraeli been involved in EHA since 2006 and has been a member of several Committees at EHA ever since. He is currently the EHA Treasurer, a member of the Executive Board, and the incoming Chair of the Research Committee. Meet Prof Izraeli and learn about what he does and why he has been volunteering for EHA for all these years.

Medical societies and patient advocates across disciplines have joined forces with EHA to call for urgent action to make clinical trials less bureaucratic and more patient-centered, efficient and cheaper.

I serve the EHA as chairman of the Study working group on “Red cells and iron” since June 2014. It was a very fruitful and exciting period.

EHA IN COLLABORATION WITH BALTIC SOCIETIES CONCLUDE THE FIRST HYBRID TUTORIAL MEETING IN EHA HISTORY!   EHA-Baltic Hematology Tutorial on Bleeding Disorders & Thrombosis August 28 – 30, 2020 Virtual & Riga, Latvia  Meeting Chairs: Prof…

Professor Robin Foà has been a member of EHA from its beginning and has participated in all EHA Congresses. He was EHA President in 2009-2011, has participated in many educational activities of the association and is currently a member of the Global Outreach Program Committee of EHA. 

Welcome to the news room of EHA25 Virtual where you can find the most relevant news items. Feel free to browse through the latest press releases below and make sure to keep an eye on this page for upcoming news items.

I am lucky to be one of the first members of the EHA (member number 34). I am involved as volunteer since 2009...

EPHA published a position paper on medicine shortages in Europe. EHA welcomes its  recommendations to address the increasing shortages crisis, which threatens patient outcomes and patient safety.

The 4^th EHA-ISHBT Hematology Tutorial on Hematological Disorders was held on February 28 and 29 in Chandigarh, India, and chaired by Prof John Gribben, Prof Neelam Varma and Prof Pankaj Malhotra.

EHA creates clinical practice guidelines for diagnosis and treatment of hematologic diseases. View the EHA methodology for guidelines, EHA Guidelines by topic and Guidelines produced by other societies and endorsed by EHA

As COVID19 progresses limited information is available in hematology to manage patient care during the pandemic. The EHA Scientific Working Group Infections in Hematology has developed key questions and answers to stand by hematology professionals in the COVID19 crisis.

The European Hematology Association (EHA) closely monitors the latest developments on the spreading of the Coronavirus (COVID-19).

I was nominated to be on the EHA Ballot in 2000 and to my surprise and happiness, I was elected as Councilor. I became President-elect in 2003 and was the EHA President 2005-2007.

Advanced therapy medicinal products (ATMPs) are a game changer for improving the lives of patients with severe to life-threatening diseases. Yet, despite fast-paced innovation in the field, few ATMPs have reached the EU market and benefited patients. The challenges facing their adoption by health systems are complex. A test case is the uptake of CAR T-cell therapy; what are the hurdles and what action is needed from stakeholders?

While health policy remains the primary responsibility of Member States, in many areas the added value of EU-level collaboration and harmonization has increased. EU initiatives in health have shown a mixed record in terms of impact, but hopes are high for the latest one, the ambitious Europe’s Beating Cancer Plan.